1. Haematologica. 2021 Jul 1;106(7):1787-1793. doi: 10.3324/haematol.2020.267252.

Interrogating the molecular genetics of chronic myeloproliferative malignancies 
for personalized management in 2021.

Mughal TI(1), Psaila B(2), DeAngelo DJ(3), Saglio G(4), Van Etten RA(5), Radich 
JP(6).

Author information:
(1)Tufts University Medical Center, Boston, MA, USA; University of Buckingham 
Medical School, Buckingham. tariq.mughal@tufts.edu.
(2)MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford.
(3)Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
(4)Orbassano University Hospital, Turin.
(5)University of California Irvine, Irvine, CA.
(6)Frederick Hutchinson Cancer Research Center, Seattle, WA.

DOI: 10.3324/haematol.2020.267252
PMCID: PMC8252942
PMID: 33657787 [Indexed for MEDLINE]